
|Videos|January 19, 2017
Drug Cost Growth Changing the Specialty Pharmacy Patient Experience
Author(s)Lauren Santye, Assistant Editor
Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.
Advertisement
Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5


























